Founded

Recent investment activity

KANDO id: 368018

Corporate information

Official name
Alexion Pharmaceuticals Incorporated
Registration country

Company type

Complement inhibition for cardiovascular and inflammatory diseases.

Funding rounds

Profile Country
CHL Medical Partners Venture capital firm focused on early-stage healthcare sectors.


Investment activity status
Active investor

Selected investments

Displaying 1 - 2 of 2
Profile Country Date Funding
Taligen Therapeutics Inc Acquisition USD 111,000,000
Enobia Pharma Corp Acquisition USD 1,100,000,000 (USD 1,100,000,000)

Current team

Past employees

Selected Products / Customers

Financials